| 1901748 | ICONS II: Identifying Continence OptioNs after Stroke | 31/10/2019 |
| 1810702 | RETAKE – Return to Work After Stroke | 31/08/2021 |
| 1808672 | Follow-up in Rivaroxaban patients in setting of thromboembolism | 31/10/2021 |
| 1808670 | STROke, Life and LeisurE Research Survey (STROLLERS) | 01/10/2020 |
| 1808655 | TRIDENT | 01/05/2020 |
| 1807654 | CONVINCE – Protocol Version 2.1 29th November 2016 | 30/10/2021 |
| 1807653 | Determinants of prognosis in stroke | 01/02/2026 |
| 1803562 | Young ESUS Patient Registry | 30/09/2019 |
| 1711537 | Genetic risk factors for cerebral small vessel disease | 01/11/2021 |
| 1707455 | SoSTART | 20/07/2022 |
| 1703392 | PD COMM – Lee Silverman Voice Treatment | 30/09/2019 |
| 1611329 | STRO 4724 | 28/02/2019 |
| 1610315 | CARD 4754 | 26/01/2023 |
| 1605252 | TASTE – Tenecteplase versus Alteplase | 31/12/2019 |
| 1603218 | RIGHT-2 | 28/08/2019 |
| 1411009 | ECST 2: The 2nd European Carotid Surgery Trial | 31/12/2022 |
| 1411004 | At Risk – Fabry | 31/12/2018 |
| 1407967 | PLORAS version 1 | 20/08/2027 |
| 1406939 | CCRN 1070 (Stroke AF) | 20/05/2019 |
| 1404912 | RESTART study | 28/02/2019 |
| 1202607 | REVEAL. | 31/12/2018 |
